close
close

Armata Pharmaceuticals Announces Appointment of Experienced Accounting and Finance Professional David House as Senior Vice President of Finance and Chief Financial Officer


Armata Pharmaceuticals Announces Appointment of Experienced Accounting and Finance Professional David House as Senior Vice President of Finance and Chief Financial Officer

LOS ANGELES, 15 August 2024 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Pursue“), a biotechnology company focused on developing highly purified, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced the appointment of an experienced life sciences accounting and finance professional David House as Senior Vice President, Finance, effective […]